Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0505-2024

Drug recall · May 29, 2024

Duloxetine Delayed-Release Cap USP 30mg recall

Why: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

Lots / codes

Lot #: J2022G, Exp: 01/01/2025

Quantity
66 bottles of 30 tablets
Company
Preferred Pharmaceuticals, Inc., Anaheim, CA
Distribution
Product distributed to CA, FL, OK, KS and CT
Initiated
May 10, 2024 · Voluntary: Firm initiated
Classified
May 21, 2024
Reported
May 29, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Duloxetine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.